Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics (PRQR) Accumulated Expenses (2021 - 2022)

Historic Accumulated Expenses for ProQR Therapeutics (PRQR) over the last 2 years, with Q4 2022 value amounting to $8.9 million.

  • ProQR Therapeutics' Accumulated Expenses fell 2799.74% to $8.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was $8.9 million, marking a year-over-year decrease of 2799.74%. This contributed to the annual value of $8.9 million for FY2022, which is 3039.63% down from last year.
  • ProQR Therapeutics' Accumulated Expenses amounted to $8.9 million in Q4 2022, which was down 2799.74% from $12.3 million recorded in Q4 2021.
  • ProQR Therapeutics' 5-year Accumulated Expenses high stood at $12.3 million for Q4 2021, and its period low was $8.9 million during Q4 2022.